The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) to treat adults and ...

Leveraging wearable and biometric technology to enhance compliance, boost efficiency, and improve workforce productivity in ...

Incretin mimetics administered by auto-injectors or pens enable significant weight reduction and offer an important means of ...

The future of aseptic small-batch manufacturing isn’t just about leading. Manufacturers who embrace automation, rethink ...